Holloway, R. W., Grendys, E. C., Lefebvre, P., Vekeman, F., & McMeekin, S. (2010). Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination with Carboplatin Versus Gemcitabine–Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review. AlphaMed Press.
Citación estilo ChicagoHolloway, Robert W., Edward C. Grendys, Patrick Lefebvre, Francis Vekeman, y Scott McMeekin. Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination With Carboplatin Versus Gemcitabine–Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review. AlphaMed Press, 2010.
Cita MLAHolloway, Robert W., et al. Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination With Carboplatin Versus Gemcitabine–Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review. AlphaMed Press, 2010.